The dynamism and quick development of Asia’s marketplaces are well-known. In recent years, the pharmaceutical business in Asia’s health care industry has grown rapidly. By 2020, pharmaceutical sales in Southeast Asia alone are estimated to reach $40 billion. As the third-largest pharmaceutical market after North America and Europe, generics are driving the pharmaceutical business in Asia Pacific. The following is a list of Asia’s top pharmaceutical companies. More than the region’s solid GDP development will fuel the pharmaceutical market’s expansion. As the world’s population grows older, governments are under increasing pressure to provide more healthcare services, and individuals are spending an increasing share of their newly acquired wealth on health care, more drugs will be purchased. Cardiovascular disease and diabetes are two of the most expensive, long-term conditions that result from unhealthy lifestyles. In order to fulfil these expanding demands, governments are investing long-term in their health infrastructures.
- Kalbe Farma’s
- Hyphens Pharma
- Takeda Pharmaceutical Company Limited
- Livzon Pharmaceutical Group Inc
- Shanghai Fosun Pharmaceutical
- Sun Pharmaceutical Industries Ltd
